| Gene
Mutation in the Ashkenazi Jewish Population
Bloom syndrome is an autosomal recessive disorder characterized clinically
by a small size and typical facial appearance, and cytogenetically by an increased
rate of chromosome breakage and sister chromatid exchange. The genomic instability
in Bloom syndrome renders patients at a much higher risk for developing multiple
types of cancers. This rare disease has a significantly higher incidence in
the Ashkenazi Jewish population, wherein the carrier frequency was estimated
at approximately 1 in 104. The Bloom syndrome gene BLM on chromosome
15q26.1 encodes a DNA helicase. While multiple BLM mutations have been
identified, a specific mutation was found to be homozygous in Ashkenazi Jewish
Bloom syndrome patients. This blmAsh mutation consists of a 6 base
deletion and 7 base insertion at nucleotide 2281 of the BLM gene, which
can be detected by a PCR-based diagnostic test. The Baylor DNA Diagnostic laboratory
is offering diagnostic testing for the Bloom syndrome blmAsh mutation
specific for the Ashkenazi Jewish population.
Reasons for Referral:
Diagnostic
testing for Ashenazi Jewish individuals with a diagnosis or possible
diagnosis of Bloom syndrome, or a positive family history of Bloom syndrome.
Testing Methodology:
PCR amplification of BLM gene sequences surrounding the blmAsh mutation
at nucleotide 2281, and detection of the wild type and 2281del6ins7
mutation by allele-specific oligonucleotide (ASO) hybridization.
Sensitivity: 98%
detection for Ashkenazi Jewish Bloom syndrome patients
Require 14 mls of
blood in EDTA tube. Consent form must accompany specimen.
Turnaround
Time:3
weeks
83788, 83914, 83912, 83898, 83891
Forms:
>> DNA
Requisition
Test Code:6012
|